CRISPR/Cas-based gene editing technologies continue to expand the capabilities of bioscience and drug discovery researchers. Existing processes have matured, while whole new applications — such as large, exogenous insertions — open exciting possibilities for efficiently modelling human disease.Are you taking full advantage of the latest CRISPR/Cas technology in your model design programs?
Generating In Vivo Research Models with CRISPR
Download this updated white paper to find out how CRISPR/Cas technologies can streamline and accelerate your genetic engineering projects, while costing significantly less than pre-CRISPR gene editing techniques.You will learn:
- How in-embryo CRISPR gene editing works
- Which advantages and limitations of CRISPR impact your designs
- When to prefer CRISPR, Easi-CRISPR, or previous editing technologies
- Why incorporating CRISPR into your program can dramatically reduce project timelines
Complete the Form to Download Your Copy »
